Skip to main content
Clinical Trials/NCT06259370
NCT06259370
Completed
Not Applicable

Benefits of Wearable Acceleration-Monitored Simulated Vigorous Intermittent Lifestyle Physical Activity (VILPA) in Young Adults

Xiao-dong Zhuang1 site in 1 country40 target enrollmentMay 12, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Activity, Motor
Sponsor
Xiao-dong Zhuang
Enrollment
40
Locations
1
Primary Endpoint
Isokinetic strength testing
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinicaltrial is to assess and compare isokinetic performance, surface electromyography, laboratory parameters, and cardiorespiratory function both before and after engaging in vigorous intermittent lifestyle physical activity(VILPA) within a healthy population.

The main question it aims to answer is:

[1] Does VILPA yield effective outcomes? Throughout the course of the trial, participants will engage in a simulated regimen of vigorous intermittent lifestyle physical activity for a duration of 8 weeks. The efficacy of the exercise protocol will be quantified and evaluated through the utilization of a wearable device.

Registry
clinicaltrials.gov
Start Date
May 12, 2023
End Date
December 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Xiao-dong Zhuang
Responsible Party
Sponsor Investigator
Principal Investigator

Xiao-dong Zhuang

Clinical Professor

Sun Yat-sen University

Eligibility Criteria

Inclusion Criteria

  • Healthy Adults
  • No exercise habits (more than 3 months)

Exclusion Criteria

  • Exercising ≥ 3 times per week;
  • the presence of chronic diseases, such as hypertension, hyperglycemic states, etc;
  • have conducted an exercise program in the past three months.

Outcomes

Primary Outcomes

Isokinetic strength testing

Time Frame: 30 minutes

Isokinetic strength testing with the Isomed 2000

Surface electromyography

Time Frame: 15 minutes

a standard surface electromyography system (MyoMove-EOW, NCC, China) was utilized. Surface electrodes were placed using the belly tendon method at 6 specified locations on both sides of the lower legs (anterior tibialis on both sides, gastrocnemius on both sides, and soleus on both sides). The electrode placement positions and operational procedures strictly adhered to the SENIAM guidelines (http://www.seniam.org). During the testing process, root mean square (RMS) and averaged electromyography (AEMG) values were collected to reflect the muscle force and motor unit recruitment of the selected muscle groups.

Secondary Outcomes

  • Blood lipid(5 minutes)

Study Sites (1)

Loading locations...

Similar Trials